Acorda Therapeutics, Inc. (NGSX)
Today, NGSX has shed (-6.67%) down -0.0005 at $.0070 with 29,206 shares in play thus far (ref. google finance Delayed: 10:44AM EDT July 17, 2013), but don't let this get you down.
Acorda Therapeutics, Inc. previously reported it has acquired two neuropathic pain management assets from NeurogesX, Inc. (OTCBB: NGSX). Qutenza® is approved by the U.S. Food and Drug Administration (FDA) for the management of neuropathic pain associated with postherpetic neuralgia. The Company also acquired NP-1998, a Phase 3 ready, prescription strength capsaicin topical solution, being assessed for the treatment of neuropathic pain. NP-1998 was previously referred to as NGX-1998.
Top Cheapest Companies To Buy For 2015
Acorda Therapeutics, Inc. (NGSX) 5 day chart:
EQ Labs, Inc. (EQLB)
Today, EQ Labs, Inc. (OTCMKTS:EQLB) (www.drinkeq.com) has surged (+9.09%) up +0.0005 at $.0060 with 1,000 shares in play thus far (ref. google finance Delayed: 3:27PM EDT July 17, 2013). Now at the current price of $.0060, EQLB would be considered to have experienced a (+900%) gain if compared to the 52 week low of $.0006.
EQ Labs, Inc. manufactures and markets energy drink products in the United States and Latin America. The company offers EQ Smart Energy Drink, in an effervescent tablet form that provides an instant energy drink once added to a beverage of choice. EQ Labs, Inc. distributes its products through national and regional distributors.
To view EQ Labs, Inc. video click link http://crwetube.com/media/eq-labs-inc-and-its-revolutionary-eq-smart-energy-.
EQ Labs, Inc. (EQLB) 5d chart:
No comments:
Post a Comment